Doxycycline should not normally be used for STI post-exposure prophylaxis

Doxycycline should not normally be used for STI post-exposure prophylaxis

November 10 2017 Doxycycline should not be used for post-exposure prophylaxis (PEP) for sexually...

MHRA issues DRUs covering gabapentin, methylprednisolone, clozapine and isotretinoin

MHRA issues DRUs covering gabapentin, methylprednisolone, clozapine and isotretinoin

October 31 2017 The medicines regulator has issued four drug safety updates (DRU) relating to...

Pneumococcal polysaccharide vaccine shortage prompts advice about prioritisation

Pneumococcal polysaccharide vaccine shortage prompts advice about prioritisation

October 23 2017 A shortage of the pneumococcal polysaccharide vaccine has promoted a Chief...

PHE issues guide on sepsis in children for health visitors and school nurses

PHE issues guide on sepsis in children for health visitors and school nurses

October 10 2017 A new guide setting out information around sepsis in children has been published...

MHRA issues Drug Safety Updates for loperamide and miconazole

MHRA issues Drug Safety Updates for loperamide and miconazole

October 4 2017 The medicines regulator, the MHRA, has issued Drug Safety Updates on two...

  • Doxycycline should not normally be used for STI post-exposure prophylaxis

    Doxycycline should not normally be used for STI post-exposure prophylaxis

    Friday, 10 November 2017 17:31
  • MHRA issues DRUs covering gabapentin, methylprednisolone, clozapine and isotretinoin

    MHRA issues DRUs covering gabapentin, methylprednisolone, clozapine and isotretinoin

    Tuesday, 31 October 2017 20:27
  • Pneumococcal polysaccharide vaccine shortage prompts advice about prioritisation

    Pneumococcal polysaccharide vaccine shortage prompts advice about prioritisation

    Monday, 23 October 2017 09:39
  • PHE issues guide on sepsis in children for health visitors and school nurses

    PHE issues guide on sepsis in children for health visitors and school nurses

    Tuesday, 10 October 2017 13:34
  • MHRA issues Drug Safety Updates for loperamide and miconazole

    MHRA issues Drug Safety Updates for loperamide and miconazole

    Wednesday, 04 October 2017 17:04

a boy with fever image cbAugust 14 2017

A number of changes have been made to the NICE guidelines and assessing and managing fever in children under 5. 

 The amendments include the addition of a recommendation cross-referencing to the NICE guideline on ‘sepsis: recognition, diagnosis and early management’. It reads:

“1.2.1.2 – Think ‘Could this be sepsis?’ and refer to the NICE guideline on sepsis: recognition, diagnosis and early management if a child presents with fever and symptoms or signs that indicate possible sepsis.”

Another addition is added under the recommendations for tests by non-paediatric practitioners (section 1.4.3). This reads:

“1.4.3.3 – When a child has been given antipyretics, do not rely on a decrease or lack of decrease in temperature to differentiate between serious and non-serious illness.”

A footnote has also been added to recommendation 1.2.2.10 and Table 1 “to highlight that some vaccinations have been found to induce fever in children younger than 3 months.”

The updated guideline CG160 replaces the May 2007 guideline, CG47.

Link:

NICE CG160 update information                  https://www.nice.org.uk/guidance/cg160/chapter/Update-information

NICE CG160 ‘Fever in under 5s: assessment and initial management’           https://www.nice.org.uk/guidance/cg160

Clinical News

November 16 2017 Scotland’s new General Medical Services contract could “reduce workload pressures and re-establish general practice as an attractive career choice,” the BMA has...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...